Member Info for Rockefellow

3.2m….short.

Target for the moment remains at 508p

Agreed!

Https://puretechhealth.com/images/PRTCCorpPresentation.pdf

Still 3.2m

Https://news.puretechhealth.com/news-releases/news-release-details/puretechs-deupirfenidone-lyt-100-demonstrates-strong-and-durable

Puretech could be .£25 plus in years to come.why sell at £2.5

Https://investors.puretechhealth.com/events/event-details/puretech-present-2024-annual-report-and-financial-results/

I reckon that UBS was a massive mistake.There was no initiation.Maybe the analyst went awol.Peel has a 508p target.

Peel Hunt has a 508p target.Jefferies 455p.Still waiting for UBS to initiate

Maybe the PE group had built up a stake and now just dumped

Potentially a $10bn pa opportunity accord to the latest presentation. SOC would imply a valuation of billions.Finals will be very interesting.

Https://puretechhealth.com/images/PRTCCorpPresentation.pdf

Limit in Puretech

Closing only

25 April last year

Zero support from UBS has left Puretech vulnerable .Perfect target for Private Equity..

Since 2pm Thursday with the stock at 124p there has been a wave of buying..One year on from Daphne leaving the stock has fallen from 230p despite fantastic progress.Surely a target.IMHO DYOR

Finals end of April

Https://www.biotechtv.com/post/luba-greenwood-state-of-possible